{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:59Z","timestamp":1790360279902,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaad.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaad.2017.02.019","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T08:46:00Z","timestamp":1507884360000},"page":"795-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Spectrum of orocutaneous disease associations"],"prefix":"10.1016","volume":"77","author":[{"given":"Jeffrey D.","family":"Cizenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian T.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Frieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Alan","family":"Menter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.coms.2008.06.002","article-title":"Wegener's granulomatosis","volume":"20","author":"Weeda","year":"2008","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"8","key":"10.1016\/j.jaad.2017.02.019_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.autrev.2015.03.005","article-title":"Granulomatosis with polyangiitis and intravenous immunoglobulins: a case series and review of the literature","volume":"14","author":"Guidelli","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2016.02.005","article-title":"Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2017.02.019_bib4","first-page":"279","article-title":"Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)","volume":"10","author":"Tarzi","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-014-0135-3","article-title":"Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab","volume":"28","author":"Geetha","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.jaad.2017.02.019_bib6","doi-asserted-by":"crossref","unstructured":"Wojciechowska J, Krajewski W, Krajewski P, et al. Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge. Clin Exp Otorhinolaryngol. 9(1), 8\u201313.","DOI":"10.21053\/ceo.2016.9.1.8"},{"issue":"11","key":"10.1016\/j.jaad.2017.02.019_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.14219\/jada.archive.2007.0166","article-title":"Oral manifestations of Wegener's granulomatosis","volume":"138","author":"Stewart","year":"2007","journal-title":"J Am Dent Assoc"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/rheumatology\/keu321","article-title":"HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis","volume":"54","author":"Watts","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jop.12030","article-title":"Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment","volume":"42","author":"Almouhawis","year":"2013","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","article-title":"Overview of the Pathogenesis of ANCA-Associated Vasculitis. Kidney Dis (Basel)","volume":"1","author":"Xiao","year":"2016","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.jaad.2017.02.019_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5604\/17322693.1197372","article-title":"Wegener's granulomatosis and pyoderma gangrenosum - rare causes of facial ulcerations","volume":"70","author":"K\u0119dzierska","year":"2016","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2012.08.010","article-title":"Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener's)","volume":"12","author":"Trimarchi","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2009.09.013","article-title":"Oral and cutaneous findings are valuable diagnostic aids in Wegener's granulomatosis","volume":"21","author":"Marzano","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib15","first-page":"CD007057","article-title":"Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis","author":"Fortin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/1744666X.2015.1008455","article-title":"Treatment of granulomatosis with polyangiitis (Wegener's)","volume":"11","author":"Pagnoux","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.iac.2012.04.003","article-title":"Diagnosis and clinical features of pemphigus vulgaris","volume":"32","author":"Venugopal","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9479","key":"10.1016\/j.jaad.2017.02.019_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2013.01.004","article-title":"Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2334\/josnusd.52.449","article-title":"Pemphigus vulgaris: effects on periodontal health","volume":"52","author":"Thorat","year":"2010","journal-title":"J Oral Sci"},{"issue":"4 Suppl","key":"10.1016\/j.jaad.2017.02.019_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.47102\/annals-acadmedsg.V33N4p63S","article-title":"Oral pemphigus vulgaris: a case report and literature update","volume":"33","author":"Robinson","year":"2004","journal-title":"Ann Acad Med Singapore"},{"issue":"10","key":"10.1016\/j.jaad.2017.02.019_bib22","first-page":"844","article-title":"Autoimmune bullous skin diseases. Part 1: Clinical manifestations","volume":"9","author":"Kneisel","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1684\/ejd.2014.2483","article-title":"Pemphigus vulgaris: approach to treatment","volume":"25","author":"Sinha","year":"2015","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.det.2007.07.001","article-title":"Vesicular and bullous disorders: pemphigus","volume":"25","author":"Baroni","year":"2007","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2334\/josnusd.50.359","article-title":"Oral pemphigus vulgaris: a case report with review of the literature","volume":"50","author":"Dagistan","year":"2008","journal-title":"J Oral Sci"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cden.2013.06.002","article-title":"Pemphigus","volume":"57","author":"Santoro","year":"2013","journal-title":"Dent Clin North Am"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly","year":"2011","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib28","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.jaad.2011.06.022","article-title":"Mucosal manifestations of pemphigus vulgaris in ear, nose, and throat; before and after treatment","volume":"67","author":"Robati","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cden.2010.08.008","article-title":"Autoimmune oral mucosal diseases: clinical, etiologic, diagnostic, and treatment considerations","volume":"55","author":"Sciubba","year":"2011","journal-title":"Dent Clin North Am"},{"issue":"175","key":"10.1016\/j.jaad.2017.02.019_bib30","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2013.6739","article-title":"Durable remission of pemphigus with a fixed-dose rituximab protocol","volume":"150","author":"Heelan","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12485162","article-title":"Immunopathology of cicatricial pemphigoid: studies of complement deposition","volume":"68","author":"Rogers","year":"1977","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0030-4220(81)90125-0","article-title":"Cicatricial pemphigoid: direct and indirect immunofluorescent studies","volume":"51","author":"Laskaris","year":"1981","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra-and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2006.10.007","article-title":"Oral pemphigoid autoantibodies preferentially target BP180 ectodomain","volume":"122","author":"Calabresi","year":"2007","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1523-1747.ep12292578","article-title":"Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1523-1747.ep12332352","article-title":"Significantly increased occurrence of HLA-DQB1*0301 allele in patientswith ocular cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2133.2001.04380.x","article-title":"Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membraneIgG production","volume":"145","author":"Setterfield","year":"2001","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/02713688908995191","article-title":"Association of HLA-DR4 with ocular cicatricial pemphigoid","volume":"8","author":"Zaltas","year":"1989","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0030-4220(86)90367-1","article-title":"Oral mucous membrane pemphigoid. A study of sixty-five patients","volume":"61","author":"Silverman","year":"1986","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bjoms.2007.07.200","article-title":"Oral mucosal diseases: mucous membrane pemphigoid","volume":"46","author":"Scully","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mcna.2014.08.006","article-title":"Oral mucosal diseases: evaluation and management","volume":"98","author":"Stoopler","year":"2014","journal-title":"Med Clin North Am"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0030-4220(82)90080-9","article-title":"Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases","volume":"54","author":"Laskaris","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/08923973.2011.608684","article-title":"Mucous membrane pemphigoid affecting the oral cavity: short review on etiopathogenesis, diagnosis and treatment","volume":"34","author":"Petruzzi","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib46","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaad.2010.10.028","article-title":"Cicatricial pemphigoid of the scalp mimicking discoid lupus erythematosus","volume":"65","author":"Das","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0030-4220(93)90012-S","article-title":"Clinical, historic, and therapeutic features of cicatricial pemphigoid. A literature review and open therapeutic trial with corticosteroids","volume":"76","author":"Vincent","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"22","key":"10.1016\/j.jaad.2017.02.019_bib48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199511303332207","article-title":"Management of acquired bullous skin diseases","volume":"333","author":"Fine","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cden.2013.07.003","article-title":"Mucous membrane pemphigoid","volume":"57","author":"Xu","year":"2013","journal-title":"Dent Clin North Am"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.oooo.2015.01.024","article-title":"World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid","volume":"120","author":"Taylor","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2012.10.018","article-title":"Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature","volume":"68","author":"Shetty","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1067\/mjd.2002.117860","article-title":"Cicatricial pemphigoid with circulating IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: Beneficial effect of adjuvant therapy with high dose intravenous immunoglobulin","volume":"46","author":"Leverkus","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clim.2001.5150","article-title":"Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid","volume":"102","author":"Sami","year":"2002","journal-title":"Clin Immunol"},{"issue":"25","key":"10.1016\/j.jaad.2017.02.019_bib54","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"issue":"3 Pt 1","key":"10.1016\/j.jaad.2017.02.019_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0190-9622(99)70111-8","article-title":"Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans","volume":"41","author":"Chorzelski","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archderm.1993.01680280071014","article-title":"Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease","volume":"129","author":"Camisa","year":"1993","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.det.2011.03.018","article-title":"Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgansyndrome): clinical presentations and pathogenesis","volume":"29","author":"Frew","year":"2011","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib58","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI115781","article-title":"Human autoantibodies against desmoplakins in paraneoplastic pemphigus","volume":"89","author":"Oursler","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib61","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bjd.13525","article-title":"Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis","volume":"172","author":"Wang","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.136.5.663","article-title":"Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases","volume":"136","author":"Chan","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib63","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archderm.136.5.652","article-title":"Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?","volume":"136","author":"Bowen","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib64","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1999.00520.x","article-title":"Elevated serum levels of interleukin-6 in paraneoplastic pemphigus","volume":"112","author":"Nousari","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000247496","article-title":"Role of cell-mediated immune reaction in blister formation of bullous pemphigoid","volume":"184","author":"Kaneko","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.02.019_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08916938908997095","article-title":"Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid","volume":"3","author":"Grando","year":"1989","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib67","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/1744666X.4.3.351","article-title":"Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus","volume":"4","author":"Vezzoli","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2017.02.019_bib69","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0190-9622(99)70145-3","article-title":"The new pemphigus variants","volume":"40","author":"Robinson","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"9408","key":"10.1016\/j.jaad.2017.02.019_bib70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman's tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.02.019_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000070972","article-title":"Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A","volume":"109","author":"Gergely","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jaad.2017.02.019_bib72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2133.2003.05269.x","article-title":"An evaluation of the usefulness of mycophenolate mofetil in pemphigus","volume":"149","author":"Powell","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib73","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib74","first-page":"564","article-title":"Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus","volume":"2","author":"Schadlow","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib75","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2017.02.019_bib76","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","article-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap","volume":"19","author":"Wojnarowska","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.02.019_bib77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1346-8138.2005.tb00839.x","article-title":"Drug-induced linear IgA bullous dermatosis","volume":"32","author":"Onodera","year":"2005","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib78","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/bjd.13154","article-title":"Ultraviolet-induced linear IgA bullous dermatosis: a case report and literature survey","volume":"171","author":"Wozniak","year":"2014","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib79","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0738-081X(00)00185-1","article-title":"Linear IgA bullous dermatosis","volume":"19","author":"Guide","year":"2001","journal-title":"Clin Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2017.02.019_bib80","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archderm.1995.01690240096016","article-title":"Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti basement membrane autoantibodies","volume":"131","author":"Chan","year":"1995","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib81","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-2133.1999.03110.x","article-title":"Adult linear IgA disease and chronic bullous disease of childhood: the association with humanlymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression","volume":"141","author":"Collier","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib82","first-page":"39","article-title":"Oral manifestations caused by the linear IgA disease","volume":"9","author":"Eguia del Valle","year":"2004","journal-title":"Med Oral"},{"key":"10.1016\/j.jaad.2017.02.019_bib83","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/sj.bdj.4804958","article-title":"Oral manifestations in linear IgA disease","volume":"153","author":"Weisenfeld","year":"1982","journal-title":"Br Dent J"},{"key":"10.1016\/j.jaad.2017.02.019_bib84","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/sj.gene.6363901","article-title":"The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3)","volume":"3 Suppl 1","author":"Quintero-Del-Rio","year":"2002","journal-title":"Genes Immun"},{"issue":"18","key":"10.1016\/j.jaad.2017.02.019_bib85","doi-asserted-by":"crossref","first-page":"11766","DOI":"10.1073\/pnas.182162399","article-title":"Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia","volume":"99","author":"Kelly","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2017.02.019_bib86","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archderm.1964.01600040005001","article-title":"Cutaneous manifestations of systemic lupus erythematosus","volume":"90","author":"Tuffanelli","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib87","first-page":"38","article-title":"Oral mucosal lesions in LE. A clinical, histopathological an immunopathological study","volume":"11","author":"Johsson","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib88","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0300-9785(84)80079-4","article-title":"Oral manifestations of lupus erythematosus","volume":"13","author":"Schiodt","year":"1984","journal-title":"Int J Oral Surg"},{"issue":"12","key":"10.1016\/j.jaad.2017.02.019_bib89","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/0961203312454589","article-title":"The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus","volume":"21","author":"Khatibi","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2017.02.019_bib90","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2133.1989.tb08215.x","article-title":"Mucosal involvement in systemic and chronic cutaneous lupus erythematosus","volume":"121","author":"Burge","year":"1989","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib91","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-0560.2006.00652.x","article-title":"Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate","volume":"34","author":"Louren\u00e7o","year":"2007","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0560.2001.280101.x","article-title":"The cutaneous pathology of lupus erythematosus: a review","volume":"28","author":"Crowson","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2017.02.019_bib93","first-page":"830","article-title":"Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.02.019_bib94","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/0961203316628997","article-title":"Treatment of cutaneous lupus erythematosus: current practice variations","volume":"25","author":"Reich","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2017.02.019_bib95","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat Genet"},{"issue":"9853","key":"10.1016\/j.jaad.2017.02.019_bib96","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn's disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2017.02.019_bib97","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ibd.20043","article-title":"Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts","volume":"13","author":"Tuvlin","year":"2007","journal-title":"Infl amm Bowel Dis"},{"key":"10.1016\/j.jaad.2017.02.019_bib98","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1468-3083.2009.03304.x","article-title":"Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases","volume":"24","author":"Louren\u00e7o","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199102000-00008","article-title":"Oral manifestations of Crohn's disease. An analysis of 79 cases","volume":"13","author":"Plauth","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2017.02.019_bib100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0757.1994.tb00030.x","article-title":"Crohn's disease: orofacial considerations and disease pathogenesis","volume":"6","author":"Kalmar","year":"1994","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.jaad.2017.02.019_bib101","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","article-title":"National Cooperative Crohn\u2019s Disease Study: extraintestinal manifestations and perianal complications","volume":"77","author":"Rankin","year":"1979","journal-title":"Gastroenterology"},{"issue":"46","key":"10.1016\/j.jaad.2017.02.019_bib102","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.3748\/wjg.v19.i46.8571","article-title":"Oral manifestation in inflammatory bowel disease: a review","volume":"19","author":"Lankarani","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib103","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1601-0825.2012.01918.x","article-title":"Biologics in oral medicine: oral Crohn's disease and orofacial granulomatosis","volume":"18","author":"O'Neill","year":"2012","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rdc.2007.10.001","article-title":"Genetics and genomic studies in scleroderma (systemic sclerosis)","volume":"34","author":"Agarwal","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2017.02.019_bib106","article-title":"Orofacial manifestations of scleroderma. A literature review","author":"Hadj Said","year":"2016","journal-title":"Rev Stomatol Chir Maxillofac Chir Orale"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib107","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22490","article-title":"Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III","volume":"67","author":"Baron","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.jaad.2017.02.019_bib108","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3899\/jrheum.090668","article-title":"Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis","volume":"37","author":"Herrick","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib110","first-page":"166","article-title":"Treatment of early diffuse systemic sclerosis skin disease","volume":"31(2 Suppl 76)","author":"Frech","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib111","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.tripleo.2010.12.020","article-title":"Chronic ulcerative stomatitis: evidence of autoimmune pathogenesis","volume":"111","author":"Carlson","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib112","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.oooo.2015.07.018","article-title":"The diagnostic challenges of separating chronic ulcerative stomatitis fromoral lichen planus","volume":"120","author":"Qari","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2017.02.019_bib113","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0190-9622(90)70027-F","article-title":"Chronic ulcerative stomatitis associated with a specific immunologic marker","volume":"22","author":"Jaremko","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib114","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tripleo.2007.02.013","article-title":"Chronic ulcerative stomatitis: diagnostic and management challenges\u2013four new cases and review of literature","volume":"104","author":"Islam","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"7488","key":"10.1016\/j.jaad.2017.02.019_bib115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib116","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/art.24572","article-title":"Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important","volume":"60","author":"Lundstr\u00f6m","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.02.019_bib117","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1756-185X.2012.01717.x","article-title":"A study of the prevalence of sicca symptoms and secondary Sjogren's syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile","volume":"15","author":"Haga","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaad.2017.02.019_bib118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1590\/S0104-42302011000300015","article-title":"Secondary Sjogren's syndrome and disease activity of rheumatoid arthritis","volume":"57","author":"Antero","year":"2011","journal-title":"Rev Assoc Med Bras"},{"issue":"12","key":"10.1016\/j.jaad.2017.02.019_bib119","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.joms.2011.02.131","article-title":"Temporomandibular joint problems and periodontal condition inrheumatoid arthritis patients in relation to their rheumatologic status","volume":"69","author":"Garib","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-5712(93)90023-J","article-title":"The temporomandibular joint in rheumatoid arthritis: Correlations between clinical and tomographic features","volume":"21","author":"Goupille","year":"1993","journal-title":"J Dent"},{"issue":"6","key":"10.1016\/j.jaad.2017.02.019_bib121","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1902\/jop.2008.070501","article-title":"Association among rheumatoid arthritis, oral hygiene, and periodontitis","volume":"79","author":"Pischon","year":"2008","journal-title":"J Periodontol"},{"issue":"2","key":"10.1016\/j.jaad.2017.02.019_bib122","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"Rheumatoid arthritis: a review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.02.019_bib123","series-title":"Rheumatoid arthritis: frontiers in pathogenesis and treatment","first-page":"219","article-title":"Rheumatoid arthritis: clinical picture and its variants","author":"Lems","year":"2000"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib124","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02041550","article-title":"Rheumatoid vasculitis: diagnostic and therapeutic decisions","volume":"2","author":"Panush","year":"1983","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib126","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.2002.04933.x","article-title":"Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis","volume":"147","author":"Chen","year":"2002","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.02.019_bib127","first-page":"507","article-title":"The frequency of leg ulceration in rheumatoid arthritis: a survey","volume":"10","author":"Thurtle","year":"1983","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.02.019_bib128","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/rheumatology\/40.7.816","article-title":"Leg ulcers in patients with rheumatoid arthritis\u2013a prospective study ofaetiology, wound healing and pain reduction after pinch grafting","volume":"40","author":"Oien","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaad.2017.02.019_bib129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.1780350105","article-title":"Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis","volume":"35","author":"van der Heijde","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jaad.2017.02.019_bib130","first-page":"585","article-title":"Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease","volume":"16","author":"Fuchs","year":"1989","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.02.019_bib131","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2009.123976","article-title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaad.2017.02.019_bib132","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9430","key":"10.1016\/j.jaad.2017.02.019_bib133","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217302396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217302396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:07:01Z","timestamp":1719515221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217302396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0190962217302396"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.02.019","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spectrum of orocutaneous disease associations","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(17)32404-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}